Judge gives initial approval to Actavis $20m antitrust deal
15-09-2020
Glenmark becomes fifth generic to be charged with US antitrust violations
02-07-2020
FTC and DoJ update antitrust guidelines
18-01-2017
JHVEPhoto / Shutterstock.com
Teva Pharmaceuticals has been charged with conspiring to fix prices, rig bids, and allocate customers for generic drugs, the US Department of Justice (DoJ) has announced.
You need a subscription to continue reading this content.
Start a subscription today to access the LSIPR website.
To access the full archive, digital magazines and special reports you will need to take out a paid subscription.
If you have already subscribed please login.
If you have any technical issues please email tech support.
For access to the complete website, archive, and to receive print publications, choose '12 MONTH SUBSCRIPTION'. For a free, two-week trial with full access, select ‘TWO WEEK FREE TRIAL’.
Teva, antitrust, probe, generic, drug, price-fixing, Sandoz, FBI, DoJ, Glenmark
